Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Hair grays due to oxidative stress and fewer functioning melanocytes.

Oxidative stress plays a significant role in vitiligo, and both skin and non-skin cells may be involved.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.